发明名称 |
Metodo de tratamiento para hcv que comprende al menos dos agentes antivirales de accion directa (daas) y ribavirina, que no incluye interferon. |
摘要 |
The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to the subject effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), an inhibitor of cytochrome P450 (e.g., ritonavir), and ribavirin. |
申请公布号 |
CL2014000777(A1) |
申请公布日期 |
2014.09.05 |
申请号 |
CL20140000777 |
申请日期 |
2014.03.28 |
申请人 |
ABBVIE, INC. |
发明人 |
BERNSTEIN, BARRY M.;MENON, RAJEEV M.;KHATRI, AMIT;MENSING, SVEN;DUTTA, SANDEEP;COHEN, DANIEL E.;PODSADECKI, THOMAS J.;BRUN, SCOTT C.;AWNI, WALID M.;DUMAS, EMILY O.;KLEIN, CHERI E. |
分类号 |
A61K31/4025;A61K31/4196;A61K31/4709;A61K31/497;A61P31/14 |
主分类号 |
A61K31/4025 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|